NAV
$23.50
AUM
$1.6M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| -11.75% | -0.35% | -7.01% | -8.96% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ISB.IC | Islandsbanki hf | 14.42% |
| 2 | ARION.IC | Arion banki hf | 12.44% |
| 3 | OCS | Oculis Holding AG | 9.50% |
| 4 | AMRQ.L | Amaroq Ltd | 5.35% |
| 5 | EMBLA.CO | Embla Medical hf | 4.95% |
| 6 | BAKKA.OL | Bakkafrost P/F | 4.93% |
| 7 | SALM.OL | SalMar ASA | 4.85% |
| 8 | MOWI.OL | Mowi ASA | 4.43% |
| 9 | JBTM | JBT Marel Corp | 4.31% |
| 10 | ALVO | Alvotech | 3.86% |
The index, which is sub-index of the MarketVector™ Total Global Equity Index, tracks the performance of common stocks (or corresponding ADRs or GDRs of “local” Icelandic companies and“non-local”companies related to the Icelandic economy. Under normal circumstances, at least 80% of the fund’s net assets, plus borrowings for investment purposes, will be invested in Icelandic equity securities. The fund is non-diversified.
Inception Date: 2025-03-26